Human-AI Collaborative Intelligence for Improving Fetal Flow Management
1 other identifier
interventional
92
1 country
2
Brief Summary
This randomized controlled study evaluates the effectiveness of explainable AI (XAI) in improving clinicians' interpretation of Doppler ultrasound images (UA and MCA) in obstetrics. It involves 92 clinicians, randomized into intervention and control groups. The intervention group receives XAI feedback, aiming to enhance accuracy in ultrasound interpretation and medical decision-making. Objectives:
- 1.To develop an interpretable model for commonly used Doppler flows, specifically the Pulsatility Index (PI) of the umbilical artery (UA) and middle cerebral artery (MCA), with the aim to provide quality feedback on Doppler spectrum images and suggest potential gate placements.
- 2.To test the effects of providing Explainable AI (XAI)-feedback for clinicians compared with no feedback on their accuracy in ultrasound interpretation and management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable healthy
Started Apr 2024
Typical duration for not_applicable healthy
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 9, 2023
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedStudy Start
First participant enrolled
April 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedMay 6, 2024
May 1, 2024
7 months
May 9, 2023
May 3, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Responses will be reviewed independently by two fetal medicine sonographers, and in case of disagreement between the two experts, a consensus will be reached.
The accuracy in each group (AI-feedback and without AI-feedback group) was defined as the percentage difference in the number of correctly managed flow images between the two groups, assessed by two fetal medicine sonographers. Correct management was defined as: Correct gate placement (multiple sites possible) AND Correct identification of flow curves that were of adequate quality to allow medical decision-making.
1 months
Secondary Outcomes (1)
Accuracy of flow image management among competence groups
1 months
Study Arms (2)
"XAI feedback on MCA/UA Doppler spectral curves and gate placement suggestions"
EXPERIMENTALThe XAI feedback group will place a gate on MCA/UA images and evaluate the Doppler spectrum with AI feedback. N=46 clinicians (Clinicians will be divided into two groups (XAI feedback \& No XAI feedback groups) of 46 each, matched for experience levels across hospitals)
"No XAI feedback"
NO INTERVENTIONThe control group will place a gate on MCA/UA images and evaluate the Doppler spectrum without AI feedback. N=46 clinicians (Clinicians will be divided into two groups (XAI feedback \& No XAI feedback groups) of 46 each, matched for experience levels across hospitals)
Interventions
This study includes 1840 ultrasound images, split into UA and MCA flow and spectrum images, each duplicated for a total of 3680 images to compare explainable AI (XAI) feedback vs. no feedback. The investigators will provide matched sets of 40 images (one for the XAI group and one for the non-XAI group) to participants. Participants are matched based on their level of experience within each hospital (Resident physicians, obstetricians, and gynecologists with obstetric ultrasound experience). All participants are instructed to place gates on the flow images of the umbilical artery and the middle cerebral artery and to assess the quality of the resulting flow curves. Specifically, for flow images, participants must identify the most appropriate gate placement. For spectral flow curves, they are to decide if the curves are of sufficient quality to guide medical management decisions.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rigshospitalet, Denmarklead
- Slagelse Hospitalcollaborator
- Technical University of Denmarkcollaborator
Study Sites (2)
Rigshospitalet
Copenhagen, Capital Region of Denmark, 2100, Denmark
Slagelse Hospital
Slagelse, Region Sjælland, 4200, Denmark
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Sealed envelopes will be used and opened at the time of inclusion of each participant. Each participant will be randomized to either AI support or no support. The allocation of participants will be performed by (XYZ) who does not have access to the randomization order.
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.d.student, medical doctor and primary investigator
Study Record Dates
First Submitted
May 9, 2023
First Posted
April 17, 2024
Study Start
April 29, 2024
Primary Completion
December 1, 2024
Study Completion
December 1, 2025
Last Updated
May 6, 2024
Record last verified: 2024-05